FSR vs MDGL
FSR (FSR) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
FSR (FSR) common stock.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
FSR does not have a complete income-statement cache yet.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
MDGL currently screens at market cap $11.56B.
Not investment advice. Open the FSR and MDGL stock pages for the full models.
Not investment advice.